ARTICLE | Clinical News
OX-NLA: Phase II data
March 24, 2008 7:00 AM UTC
Data from a double-blind, active- and placebo-controlled, Swedish Phase II trial of 25 subjects showed that cetirizine+liposomes in NLA nasal spray had local irritating characteristics that were comp...